Literature DB >> 12185325

Implantation of VX2 carcinoma into the liver of rabbits: a comparison of three direct-injection methods.

Wan-Yu Lin1, Jeonhor Chen, Yungchang Lin, Kunwang Han.   

Abstract

The efficacy of agarose in preventing VX2 carcinoma cell leakage was evaluated and the results were compared with two traditional methods. Forty-five rabbits were divided into 3 groups: Group 1, VX2 tumor cells were injected directly into the liver and no special procedure after removal of the needle; Group 2, the puncture site was gently compressed, using an alcoholic cotton gauze, for three minutes; Group 3, 0.2 ml of heated liquid agarose was injected to seal the aperture after injection of VX2 cells. The leakage rates were 80%, 53.3% and 6.6% for group 1, group 2 and group 3, respectively. We consider agarose is a useful material in preventing the leakage in the establishment of VX2 liver tumor models.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185325     DOI: 10.1292/jvms.64.649

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  10 in total

1.  Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model.

Authors:  Max Seidensticker; Sebastian Streit; Norbert Nass; Christian Wybranski; Julian Jürgens; Jan Brauner; Nadine Schulz; Thomas Kalinski; Ricarda Seidensticker; Benjamin Garlipp; Ingo Steffen; Jens Ricke; Oliver Dudeck
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

2.  Comparison of two different laparotomy methods for modeling rabbit VX2 hepatocarcinoma.

Authors:  Zhu Chen; Zhen Kang; En-Hua Xiao; Min Tong; Yu-Dong Xiao; Hua-Bing Li
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

3.  Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound.

Authors:  Wen-Tao Kong; Hai-Xia Yuan; Hao Cai; Wen-Ping Wang; Yang Tang; Xiao-Long Zhang
Journal:  Tumour Biol       Date:  2014-12-02

4.  Percutaneous US-guided implantation of Vx-2 carcinoma into rabbit liver: a comparison with open surgical method.

Authors:  Kwang-Hun Lee; Eleni Liapi; Manon Buijs; Josephina Anna Vossen; Veronica Prieto-Ventura; Labiq H Syed; Jean-Francois H Geschwind
Journal:  J Surg Res       Date:  2008-09-29       Impact factor: 2.192

5.  Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization.

Authors:  Zhen Li; Dao-Yu Hu; Qian Chu; Jian-Hong Wu; Chun Gao; Yu-Qing Zhang; Yan-Rong Huang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

6.  Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs.

Authors:  Sumeet Virmani; Kathleen R Harris; Barbara Szolc-Kowalska; Tatjana Paunesku; Gayle E Woloschak; Fred T Lee; Robert J Lewandowski; Kent T Sato; Robert K Ryu; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2008-04-18       Impact factor: 3.464

7.  Considerations for implantation site of VX2 carcinoma into rabbit liver.

Authors:  Kwang-Hun Lee; Eleni Liapi; Manon Buijs; Josephina Vossen; Kelvin Hong; Christos Georgiades; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2008-11-22       Impact factor: 3.464

8.  Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model.

Authors:  Sarah B White; Jeane Chen; Andrew C Gordon; Kathleen R Harris; Jodi R Nicolai; Derek L West; Andrew C Larson
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

9.  Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.

Authors:  Veronica Prieto; Johannes M Ludwig; Alton B Farris; Ganji Purnachandra Nagaraju; Taoreed O Lawal; Bassel El-Rayes; Hyun S Kim
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

10.  Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models.

Authors:  Zhenguang Wang; Guangjie Yang; Pei Nie; Junhua Fu; Xufu Wang; Dan Liu
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.